Scientific topics
Keywords
ITMO
Meyling Hua-Chen CHEOK PharmD, PhD
Course and current status
1. Professional Positions
Since 2009: Group Leader
“Pharmacogenomics of Acute Myeloid Leukemia”,
UMR-S1172, Lille, France
2007 - 2008: Assistant Professor
Department of Clinical Pharmacy, College of Pharmacy,
University of Tennessee, Memphis, USA
2004 - 2007: Group Leader
“Pharmacogenomics of Pediatric Acute Lymphoblastic Leukemia”
St. Jude Research Hospital, Memphis, USA
2003 - 2004 Post-doctoral Research Associate
Department of Pharmaceutical Sciences,
St. Jude Research Hospital, Memphis, USA
2. Education & Training
1999 - 2003: Ph.D. degree
“Gene Expression to Elucidate Determinants of Drug Response in Human Acute Lymphoblastic Leukemia”
Department of Clinical Pharmacy, University of Bonn, Bonn, Germany
1995 - 1998: PharmD degree
School of Pharmacy, Free University of Berlin
3. Expertise
pharmacogenomics, acute leukemia, chemoresistance, targeted drug response,
gene expression profiling, clonal heterogeneity, translational research
4. Track Record & Patents
Researcher ID: C-3822-2014
Scientific summary
My research team investigates the effect of genetic and non-genetic factors on intra- and inter-leukaemia heterogeneity and how this influences chemotherapy resistance and disease progression. We aim to develop tools to identify and track resistant leukaemia cells within the leukaemia bulk and to improve treatment to prevent or delay the evolution of drug resistance and subsequent disease relapse.
